The digital assets ecosystem is constantly evolving, and staying informed is key to making strategic portfolio decisions. Fidelity Digital Assets® is dedicated to helping investors navigate the latest market developments with resources such as our Research team’s data-driven research and in-depth analysis—offering exclusive insights.
Be the first to receive our content, including:
- Educational blogs
- Thought leadership
- Quarterly Signals reports
- News and market event analysis
Top Research
Coin Report: Bitcoin (BTC) Fidelity Digital Assets’ “Coin Report” series provides readers with a foundational understanding of digital assets, examining each network’s strengths and weaknesses in the familiar format of a traditional initiation report. This report specifically highlights Bitcoin and explores its long-term potential in the digital asset market. Read Now. |
Coin Report: Ethereum (ETH) This installment of the "Coin Report" series examines the long-term potential of Ethereum as a leading smart contract platform and the second largest digital asset by market cap. Read Now. |
Bitcoin's Potential as a Leading Macro Asset This high-level blog analyzes bitcoin's correlation with inflation expectations and explores what it may reveal about bitcoin’s potential as a macro asset. Read Now. |
Sign up for free research and insights
(All fields below are required)
Digital assets are speculative and highly volatile, can become illiquid at any time, and are for investors with a high-risk tolerance. Investors in digital assets could lose the entire value of their investment.
Custody and trading of digital assets are provided by Fidelity Digital Asset Services, LLC, which is chartered as a limited purpose trust company by the New York State Department of Financial Services to engage in virtual currency business (NMLS ID 1773897). FDA LTD and FDA Ireland rely on FDAS LLC for these services. FDA LTD is registered with the Financial Conduct Authority under the U.K.’s Money Laundering Regulations. The Financial Ombudsman Service and the Financial Services Compensation Scheme do not apply to the cryptoasset activities carried on by FDA LTD. FDA Ireland is incorporated in Ireland as a private limited company and provides certain virtual asset services described in the Criminal Justice (Money Laundering and Terrorist Financing) Acts 2010 to 2021. FDA Ireland is registered with the Central Bank of Ireland for anti-money laundering and countering the financing of terrorism (AML/CFT) purposes only (C526991).
To the extent this communication constitutes a financial promotion in the U.K., it is issued only to, or directed only at, persons who are: (i) investment professionals within the meaning of Article 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "FPO"); (ii) high net worth companies and certain other entities falling within Article 49 of the FPO; and (iii) any other persons to whom it may lawfully be communicated.
This information is not intended for distribution to, or use by, anyone in any jurisdiction where such distribution would be contrary to local law or regulation. Persons accessing this information are required to inform themselves about and observe such restrictions.
FDAS LLC, FDA LTD, and FDA Ireland do not provide tax, legal, investment, or accounting advice. This material is not intended to provide, and should not be relied on, for tax, legal, or accounting advice. Tax laws and regulations are complex and subject to change. You should consult your own tax, legal, and accounting advisors before engaging in any transaction.
Views expressed are as of the date indicated, based on the information available at that time, and may change based on market or other conditions. Unless otherwise noted, the opinions provided are those of the speaker or author and not necessarily those of Fidelity Digital Assets or its affiliates. Fidelity Digital Assets does not assume any duty to update any of the information.
Fidelity Digital Assets is a registered service mark, and the Fidelity Digital Assets logo is a service mark of FMR LLC.
© 2025 FMR LLC. All rights reserved.
1143506.2.0